8 September 2014 Preclinical evaluation of a novel cyanine dye for tumor imaging with <italic<in vivo</italic< photoacoustic imaging
Author Affiliations +
J. of Biomedical Optics, 19(9), 090501 (2014). doi:10.1117/1.JBO.19.9.090501
Abstract
Photoacoustic imaging (PA imaging or PAI) has shown great promise in the detection and monitoring of cancer. Although nanocarrier-based contrast agents have been studied for use in PAI, small molecule contrast agents are required due to their ease of preparation, cost-effectiveness, and low toxicity. Here, we evaluated the usefulness of a novel cyanine dye IC7-1-Bu as a PAI contrast agent without conjugated targeting moieties for
© 2014 Society of Photo-Optical Instrumentation Engineers (SPIE)
Takashi Temma, Satoru Onoe, Kengo Kanazaki, Masahiro Ono, Hideo Saji, "Preclinical evaluation of a novel cyanine dye for tumor imaging with <italic<in vivo</italic< photoacoustic imaging," Journal of Biomedical Optics 19(9), 090501 (8 September 2014). http://dx.doi.org/10.1117/1.JBO.19.9.090501
JOURNAL ARTICLE
3 PAGES


SHARE
KEYWORDS
Tumors

In vivo imaging

Photoacoustic imaging

Luminescence

Cancer

In vitro testing

Tissues

Back to Top